Callan Capital, LLC Connect Biopharma Holdings LTD Transaction History
Callan Capital, LLC
- $1.35 Billion
- Q1 2025
A detailed history of Callan Capital, LLC transactions in Connect Biopharma Holdings LTD stock. As of the latest transaction made, Callan Capital, LLC holds 80,000 shares of CNTB stock, worth $60,000. This represents 0.0% of its overall portfolio holdings.
Number of Shares
80,000
Previous 80,000
-0.0%
Holding current value
$60,000
Previous $96,000
54.17%
% of portfolio
0.0%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding CNTB
# of Institutions
15Shares Held
2.93MCall Options Held
0Put Options Held
0-
Bml Capital Management, LLC Zionsville, IN2.09MShares$1.57 Million0.93% of portfolio
-
Ubs Oconnor LLC Chicago, IL269KShares$201,7090.01% of portfolio
-
Choreo, LLC Minneapolis, MN161KShares$120,6500.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny115KShares$86,1000.0% of portfolio
-
Black Rock Inc. New York, NY104KShares$77,9180.0% of portfolio
About Connect Biopharma Holdings Ltd
- Ticker CNTB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,015,800
- Market Cap $41.3M
- Description
- Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, focuses on the discovery and development of immune modulators for the treatment of serious autoimmune diseases and inflammation. The company's lead product candidate is CBP-201, an anti-interleukin-4 receptor alpha antibody, which is in Phase IIb clinical trial for t...